Nascent Lifescience Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.21 M
- Company Age 14 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 4.00 M
- Revenue Growth -76.38%
- Profit Growth -59.18%
- Ebitda -26.30%
- Net Worth 7.74%
- Total Assets 6.59%
About Nascent Lifescience
Nascent Lifescience Private Limited (NLPL) is a Private Limited Indian Non-Government Company incorporated in India on 14 September 2010 and has a history of 14 years and five months. Its registered office is in Ahmedabad, Gujarat, India.
The Corporate was formerly known as Nestent Pharmaceuticals Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.21 M.
The company currently has active open charges totaling ₹4.00 M.
Sureshkumar Vekariya and Nikunj Vekariya serve as directors at the Company.
Company Details
-
Location
Ahmedabad, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U24230GJ2010PTC062297
-
Company No.
062297
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
14 Sep 2010
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
What products or services does Nascent Lifescience Private Limited offer?
Nascent Lifescience Private Limited offers a wide range of products and services, including Pharma & Bioanalytical Services, Pharmaceutical Third Party Manufacturing, Pain Relief Drugs & Pharmaceuticals, Pain Killers.
Who are the key members and board of directors at Nascent Lifescience?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sureshkumar Vekariya
|
Additional Director | 18-Feb-2013 | Current |
|
Nikunj Vekariya
|
Additional Director | 18-Feb-2013 | Current |
Financial Performance of Nascent Lifescience.
Nascent Lifescience Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 76.38% decrease. The company also saw a substantial fall in profitability, with a 59.18% decrease in profit. The company's net worth moved up by a moderate rise of 7.74%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nascent Lifescience?
Unlock access to Nascent Lifescience's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Xylys Laboratories LlpSureshkumar Vekariya is a mutual person
-
Nirved Multiservices Llp
Sureshkumar Vekariya is a mutual person
-
Nriva Technologies Private Limited
Sureshkumar Vekariya is a mutual person
Charges (Loans)
₹4.00 M
₹0
Charges Breakdown by Lending Institutions
- Canara Bank : 0.40 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 01 Dec 2014 | Canara Bank | ₹4.00 M | Open |
How Many Employees Work at Nascent Lifescience?
Unlock and access historical data on people associated with Nascent Lifescience, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nascent Lifescience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nascent Lifescience's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
